Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the

Jaime S Rosa1, Rebecca L Flores, Stacy R Oliver

  • 1Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, USA. jsrosa@uci.edu

Insights

Poor glycemic control in children with Type 1 diabetes (T1DM) elevates inflammation, impacting cardiovascular health. Optimizing exercise requires understanding how hyperglycemia affects inflammatory responses in T1DM children.

Area of Science:

  • Pediatric Endocrinology
  • Exercise Physiology
  • Immunology

Background:

  • Type 1 diabetes (T1DM) is linked to cardiovascular complications, partly due to chronic inflammation from hyperglycemia.
  • Physical activity offers anti-inflammatory benefits, but mechanisms in T1DM children are not fully understood.
  • Optimizing exercise for cardiovascular health in T1DM children necessitates understanding exercise-related anti-inflammatory strategies.

Purpose of the Study:

  • To investigate the impact of prior hyperglycemia on resting and exercise-induced inflammation in T1DM children.
  • To assess plasma IL-6 levels in relation to glycemic control preceding exercise.
  • To determine if glycemic control influences inflammatory adaptation to exercise in T1DM children.

Main Methods:

  • Continuous glucose monitoring (CGMS) for 63 hours before exercise in T1DM children.
  • A 30-minute intermittent cycling exercise protocol at ~80% VO2max.
  • Plasma IL-6 measurements at baseline, end-exercise, and 30 minutes post-exercise, with controlled euglycemia during and after exercise.

Main Results:

  • Plasma IL-6 levels were lowest in children with the best glycemic control (lowest average glycemia).
  • Higher average glycemia over 3 days correlated with increased baseline IL-6 levels.
  • Greater hyperglycemic exposure was associated with proportionally higher IL-6 changes at end-exercise and post-exercise.

Conclusions:

  • Poor glycemic control in T1DM children, even in the days preceding exercise, can impair inflammatory adaptation.
  • Understanding the molecular effects of physical activity is crucial for developing effective exercise regimens for T1DM children.
  • This study highlights the need for improved glycemic management to maximize the anti-inflammatory benefits of exercise in T1DM.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...